Develops precision RNA therapeutics by editing multiple exons to treat diseases beyond the reach of current gene editing methods.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ascidian Therapeutics develops precision RNA therapeutics using a proprietary RNA exon editing platform designed to rewrite RNA and address the underlying causes of disease. Their technology enables the replacement of multiple exons in RNA, offering a novel approach to treat diseases not addressed by current gene editing methods while maintaining natural gene expression patterns and levels.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ascidian Therapeutics Management Team
Investors
Apple Tree Partners
Ascidian Therapeutics Valuations & Financials
View real-time NPM data on Ascidian Therapeutics stock including daily Ascidian Therapeutics stock price estimates, valuation history, and historical share price information. Access Ascidian Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Ascidian Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Ascidian Therapeutics? Get in touch to learn more.
Similar Companies
like Ascidian Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Parabilis Medicines
Healthcare & Life Sciences
Develops innovative peptide therapeutics to treat severe diseases through proprietary technology that creates highly tunable drug candidates.
Walden Robotics
Delivers full-stack robotics solutions for automating manufacturing and logistics tasks with integrated hardware, software, and Physical AI.
InterWell Health
Healthcare & Life Sciences
Healthcare company delivering value-based kidney care through physician partnerships, care coordination, and analytics to improve patient outcomes.
ChipAgents
Develops autonomous intelligence platforms to accelerate chip design and hardware verification workflows for semiconductor engineering teams.
LifeMine
Healthcare & Life Sciences
Exploits fungi to discover and develop novel drugs through genome mining.
Light Power
Lets businesses offer their own branded electricity plans through an embedded platform that handles licensing and billing.
Octave
Healthcare & Life Sciences
Virtual mental health platform providing therapy and coaching services through licensed professionals for stress, anxiety and emotional support.
Alcatraz AI
Provides frictionless physical security, real-time tailgating detection, and privacy-compliant identity verification for high-security facilities.
FAQ
We have answers
Ascidian Therapeutics stock does not trade on public stock exchanges. Ascidian Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ascidian Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ascidian Therapeutics Stock does not trade on public stock exchanges. In order to sell Ascidian Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ascidian Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ascidian Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ascidian Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ascidian Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ascidian Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ascidian Therapeutics is a private company and has not had an IPO. There is currently no Ascidian Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ascidian Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
